Epstein Secrets

r. Linnie Golightly of our Center for G=obal Health/Infectious Disease Division for the past decade, work=ng together closely to develop multiplexed PCR-LDR assays for Category=A Biothreat agents, including all the major viral hemorrhagic fever viruses (VHF; ebolavirus, marburgvirus Crimean Congo=nbsp;he

p multiplexed PCR-LDR assays for Category=A Biothreat agents, including all the major viral hemorrhagic fever viruses (VHF; ebolavirus, marburgvirus Crimean Congo=nbsp;hemorrhagic fever virus, Lassa fever virus, Rift Valley fever vir=s, Dengue virus, and Yellow fever virus). (Kindly see belo= abstract of manu

r. Linnie Golightly of our Center for =lobal Health/Infectious Disease Division for the past decade, wo=king together closely to develop multiplexed PCR-LDR assays for Categ=ry A EFTA_R1_01775796 EFTA02592731 Biothreat agents, including all the major viral hemorrhagic fever viruses (VHF; ebolavirus, m

abling simultaneous identification of the pathogens. The assay wa= evaluated on 32 different isolates associated with VHF (ebolavirus,4>marburgvirus Crimean Congo hemorrhagic fever virus, Lassa fever =irus, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia vir

r. Linnie Golightly of our Center for G=obal Health/Infectious Disease Division for the past decade, work=ng together closely to develop multiplexed PCR-LDR assays for Category=A Biothreat agents, including all the major viral hemorrhagic fever viruses (VHF; ebolavirus, marburgvirus Crimean Congo=nbsp;h

ng simultaneous identification of the pathogens. The assay was=evaluated on 32 different isolates associated with VHF (ebolavirus,&nb=p;marburgvirus Crimean Congo hemorrhagic fever virus, Lassa fever viru=, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia vir